Should subjects who used psoralen suntan activators be screened for melanoma?

Annals of Oncology

Volumn 8, Issue 5, 1997, Pages 435-437

  Autier, P ^a   Dore J F ^b,d   Cesarini J P ^c   Boyle, P ^a  

^a EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^b INSERM   (France)

^c FONDATION OPHTALMOLOGIQUE ADOLPHE DE ROTHSCHILD   (France)

^d CENTRE LÉON BÉRARD   (France)

Author keywords

Attributable risk; Early detection; Melanoma; Psoralens

Indexed keywords

BERGAMOT OIL; BERGAPTEN; CARCINOGEN; PSORALEN; SUNSCREEN;

ACTINIC KERATOSIS; ARTICLE; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER RISK; CANCER SCREENING; CANCER SURVIVAL; CARCINOGENICITY; HUMAN; MELANOMA; NEVUS; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; SUN; ULTRAVIOLET B RADIATION;

EID: 0030872940     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1008205513771     Document Type: Article

References (12)

1. Thompson SC, Jolley D, Marks R. Reduction of solar keratoses by regular sunscreen use. N Engl J Med 1993; 329: 1147-51.
2. Naylor MF, Boyd A. Smith DW et al. High sun protection factor sunscreens in the suppression of actinic neoplasia. Arch Dermatol 1995; 131: 170-75.
3. Autier P, Doré JF, Schifflers E et al. for the EORTC Melanoma Cooperative Group. Melanoma and use of sunscreens. An EORTC case-control study in Germany, Belgium and France. Int J Cancer 1995; 61: 749-55.
4. Westerdahl J, Olsson H, Masback A et al. Is the use of sunscreen a risk factor for malignant melanoma? Melanoma Res 1995; 5: 59-65.
5. Ashwood-Smith MJ. Possible cancer hazard associated with 5-methoxypsoralen in suntan preparations. BMJ 1979; 2: 1144.
6. Zajdela F, Bisagni E. 5-Methoxypsoralen, the melanogenic additive in sun-tan preparations, is tumorigenic in mice exposed to 365 nm UV radiation. Carcinogenesis 1981; 2: 121-7.
7. Morison WL. To tan or not to tan: A burning question. Arch Dermatol 1989; 125: 1258-60.
8. Chadwick CA, Potten CS, Cohen AJ, Young AR. The time of onset and duralion of 5-methoxypsoralen photochemoprotection from UVR-induced DNA damage in human skin. Br J Dermatol 1994; 131: 483-494.
9. Hennekens HS, Buring JE, Mayrent SL. Epidemiology in Medicine. Boston: Little Brown and Co 1987; 87-90.
10. Parkin D, Muir C, Whelan S et al. Cancer Incidence in Five Continents. International Agency for Research on Cancer. IARC Scientific Publication No. 120, Lyon 1992.
11. Visser O, Coebergh JWW, Schouten LJ (eds). Incidence of Cancer in the Netherlands 1990. Utrecht: Netherlands Cancer Registry 1990.
12. Baccard M, Havard S, Souques M. Groupe Mélanomede PETRI. Elude prospective de l'incidence du mélanome dans la Région Ile de France en 1994, Colloque AP-HP: Europe against Cancer 'Epidemiologie et Prévention des Mélanomes'. Paris. February 9, 1996(Abstr).